CD8A and COVID-19: In human, Hannoun et al. recently identified some HIV-1-derived peptides that can potentially bind to HLA-E54 and the use of HLA-E-restricted CD8 T cell to improve immunotherapy in COVID-19 patients has recently been proposed18.